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Abstract
Background: Chronic pain is a public health problem although there is a paucity of prevalence data from countries
in the Middle East and North Africa. The aim of this study was to estimate the prevalence of chronic pain and
neuropathic pain in a sample of the general adult population in Libya.
Methods: A cross-sectional telephone survey was conducted before the onset of the Libyan Civil War (February 2011) on
a sample of self-declared Libyans who had a landline telephone and were at least 18 years of age. Random sampling of
household telephone number dialling was undertaken in three major cities and interviews conducted using an Arabic
version of the Structured Telephone Interviews Questionnaire on Chronic Pain previously used to collect data
in Europe. In addition, an Arabic version of S-LANSS was used. 1212 individuals were interviewed (response
rate = 95.1 %, mean age = 37.8 ± 13.9 years, female = 54.6 %).
Results: The prevalence of chronic pain ≥ 3 months was 19.6 % (95 % CI 14.6 % to 24.6 %) with a mean ± SD
duration of pain of 6 · 5 ± 5 · 7 years and a higher prevalence for women. The prevalence of neuropathic pain
in the respondents reporting chronic pain was 19 · 7 % (95 % CI 14 · 6-24 · 7), equivalent to 3 · 9 % (95 % CI 2 · 8
to 5 · 0 %) of the general adult population. Only, 71 (29 · 8 %) of respondents reported that their pain was being
adequately controlled.
Conclusions: The prevalence of chronic pain in the general adult population of Libya was approximately 20 %
and comparable with Europe and North America. This suggests that chronic pain is a public health problem in
Libya. Risk factors are being a woman, advanced age and unemployment. There is a need for improved health
policies in Libya to ensure that patients with chronic pain receive effective management.
Keywords: Pain, Epidemiology, Prevalence, Chronic pain, Libya, Middle East and North Africa (MENA),
Developing world
Background
Chronic pain is a global public health concern because
of its high prevalence, high economic costs, and negative
impact on the quality of life of individuals and their fam-
ilies. It is claimed that the impact of chronic pain on in-
dividuals and the burden of chronic pain on societies is
similar across the world, although the prevalence and
determinants of chronic pain may vary within and be-
tween regions because of differences in standards of
living, healthcare resources and the high prevalence of
pain-generating diseases [1]. There has been limited
research on the epidemiology of pain in countries of the
Middle East and North Africa (MENA). Research to date
suggests that there is likely to be a high prevalence of
conditions that contribute to neuropathic pain including
HIV/AIDs, diabetes mellitus, cancer and traumatic injur-
ies associated with accidents and on-going conflicts [2–
5]. In 2010 an expert panel claimed that much neuro-
pathic pain remained underdiagnosed in the Middle East
and North Africa [6].
Most Middle East and North African countries are
categorised as ‘developing’ with Human Development
Indices (HDI) from 0 · 576 in Yemen to 0 · 935 in Israel.
The HDI is a measure of the impact of economic pol-
icies on quality of life and reflects a nation’s health and
longevity, education and living standards. Recently, we
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conducted a systematic review that found no correlation
between HDI and the prevalence of chronic pain [7].
Prevalence in countries with a HDI <0 · 9 was 33 · 9 % ±
14 · 5 % and significantly higher than prevalence in coun-
tries with a HDI ≥0 · 9 (29 · 9 % ± 12 · 7 %). Our analysis
was undermined by heterogeneity in study methodolo-
gies and contamination of samples by comorbidities
resulting in large variation in estimates of prevalence by
different investigating teams. Most of the data for coun-
tries with an HDI < 0 · 9 was generated from 3 multi-
national epidemiological studies [8–10] with no studies
that focussed on a country with a HDI <0 · 9 being eli-
gible for review.
Previously, we have translated the Arabic version of
the Structured Telephone Interviews Questionnaire on
Chronic Pain that had been used in the Pain in Europe
survey [10] and demonstrated its reliability and linguistic
validity for use in a Libyan population [11]. In February
2010, we used the Arabic version of the Structured Tele-
phone Interviews Questionnaire on Chronic Pain in a
pilot study in the city of Derna, Libya that estimated
prevalence of chronic pain ≥3 months to be 25 · 0 %
(95 % CI, 16 · 7 % to 33 · 3 %)[10]. We also found that
50 · 0 % (95 % CI: 30 · 8 % to 69 · 2) of the respondents
who reported chronic pain scored ≥12 on the Arabic
version of the S-LANSS suggesting that their pain was
predominantly neuropathic in origin [11]. It is important
to confirm these estimates generated from a small sam-
ple size. A telephone survey that addresses methodo-
logical issues arising from our pilot study is needed.
In Libya, pain management is not a high priority. The
availability of opioid medication is limited and pain-
related government policies are absent. The aim of the
present study was to estimate the prevalence of chronic
pain in Libya with particular reference to neuropathic
pain. The study was designed to evaluate the relation-
ship between the chronic pain and socio-demographic
factors; to describe the pain characteristics among
people who suffer from chronic pain; and to gather in-
formation on aetiology, diagnosis, severity, duration, im-
pact on quality of life, treatments and attitudes about
living with chronic pain.
Methods
Study design
A cross-sectional telephone interview survey approach
was used to gather data from 1 June 2010 to 3 September
2010, before the onset of the Libyan conflict in February
2011. The study was approved by the Research Ethics
Committees of Leeds Metropolitan University (now Leeds
Beckett University), Leeds, UK and the Faculty of Medical
Technology, Derna, Libya.
Methodology was developed following the results of pilot
studies that had translated the following questionnaires
into Arabic and validated their use for telephone inter-
views in Libyan populations [11–13]:
a) The Structured Telephone Interviews Questionnaire
on Chronic Pain which was used to collect the data
for the Pain in Europe survey in 2006 [10]. This
questionnaire was used to estimate the prevalence of
chronic pain of ≥3 months duration and to gather
information about aetiology, treatments and
attitudes about living with chronic pain [12];
b) The Self-completed Leeds Assessment of Neuropathic
Symptoms and Signs (S-LANSS) questionnaire to esti-
mate prevalence of neuropathic pain [11, 13]
Sample population and size
The most recent census conducted in 2005 found that
97 % of the Libyan population were of Arab or a mixture of
Arab and Berber ethnicity. The remaining 3 % of the Libyan
population were of Greek, Maltese, Italian, Egyptian, Paki-
stani, Turkish, Indian, Tunisian and sub-Saharan origin. A
sample population that reflected this ethnic mix was ob-
tained by gathering data from the capital cities of the three
main regions in Libya. These cities also had the most devel-
oped telephone systems. They were:
a) Tripoli, the nation’s capital within the Tripolitania
region (population = 911,643, predominantly Arabic);
b) Benghazi, the capital of Cyrenaica region
(population = 685,367, predominantly Arabic);
c) Sabha, the capital of Fezzan region (population =
137,307, mixture of Arab and sub-Saharan African
Black descent).
Sample size was calculated using data collected from a
pilot study in Derna city [12]. Raosoft software (Federal
Way, Washington, USA) was used to calculate the number
of people required to be screened to detect a 25 % preva-
lence of pain, with a 3 % margin of error (95 % power at the
5 % significant level). A total of 1212 people were required.
Data collection and processing
Data was collected using telephone numbers that were ran-
domly selected using computer-generated random num-
bers (www.random.org) and a random digit telephone
dialling system. Any household resident aged 18 and over
who answered the telephone was invited to participate in
the survey. Respondents were asked if there was more than
one adult in the household at the time of the call and if so
one of these adults was selected at random.
Telephone interviews
Telephone calls making the first point of contact with
potential participants were made between 10:00 am and
10:00 pm Saturday to Thursday from 1 June 2010 to 3
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September 2010. A telephone call was considered unsuc-
cessful if the number did not connect at the time of call-
ing, was connected to a fax machine, or an engaged tone
was encountered and/or no one replied after 3 repeat
calls at different times on different days. A call was also
considered unsuccessful if there was nobody in the
house eligible for the study at the time of the call.
Telephone interviews were conducted in Arabic by
Libyan nationals using Libyan dialect and following
scripts and questionnaires written in Arabic. Interviews
consisted of an introduction to study, screening to
establish the presence or otherwise of chronic pain, and
an in-depth interview consisting of the Structured Tele-
phone Interview Questionnaire on Chronic Pain and S-
LANSS (Self-completed Leeds Assessment of Neuropathic
Symptoms and Signs). The first point of contact was con-
ducted by the principal investigator (RAE) and two aca-
demic staff members from the Faculty of Medical
technology in Derna who had received training on tele-
phone interview techniques specific to the study.
Screening
The interviewer read verbatim an Arabic translation of
the Structured Telephone Interviews Questionnaire on
Chronic Pain [10] and transcribed answers onto hard
copy. Questions 1–12 were used to determine the preva-
lence of pain, its cause and treatments used. Respondents
were categorised as having chronic pain of ≥3 months
according to their answer to question 6 “For how long
have you suffered pain due to your illness or medical con-
dition?” The criteria used to determine whether a re-
spondent was categorised as having chronic pain was
based on the definition from the International Association
for the Study of Pain which uses a cut point of ≥3 months.
This differs from that used in the original Structured Tele-
phone Interviews Questionnaire on Chronic Pain which
used a cut point of ≥6 months.
Respondents categorised without chronic pain were
asked 7 demographic questions after which the interview
was terminated. Respondents categorised with chronic
pain were asked a further 44 questions about their pain
including Question 7 “When was the last time you
experienced pain?” which was used to confirm that re-
spondents were correctly categorised as having pain
of ≥3 months. Respondents categorised with chronic
pain were then invited to take part in the in-depth inter-
view either immediately or on an alternative date. If they
declined the invitation for an in-depth-interview they were
asked 7 demographic questions (Q38-44) and the inter-
view was terminated.
In-depth interview
In-depth-interviews were performed by the principal in-
vestigator (RAE). In-depth-interviews were conducted by
reading the Arabic version of the Structured Telephone
Interviews Questionnaire on Chronic Pain verbatim to
gather information about pain, impact on quality of life
(including daily activities), treatments used and attitudes
about living with chronic pain. Respondents were then
invited to answer questions read from an Arabic transla-
tion of the S-LANSS. Interviews were terminated after
this data was gathered.
Data analysis and quality control
Data was processed using Statistical Package for Social
Sciences (SPSS) version 19.0. Descriptive statistics were
used to analyse report demographics, pain location,
cause and duration of pain, pain intensity and treat-
ments used. Univariate odds ratios (OR) of respondents
who had chronic pain were calculated for each demo-
graphic and different groups. When there were more
than one group in any category, e.g. age groups, a refer-
ence group was chosen in line with those used in previ-
ous studies [14, 15].
Multivariate analysis was conducted through the logis-
tic regression function of SPSS with the method chosen
as Enter with the dependent variable being the answer to
the question (for example, “Are you adult aged 18 and
older who suffers from pain from an illness or medical
condition?”) and the independent variable being sex, age
groups, marital and employment status. Mutual adjusted
odds ratios were calculated with all independent variables
taken into account. Furthermore, a matrix Spearman Cor-
relation was conducted to investigate co-linearity between
demographic factors.
Prevalence data was reported as percentage with mean
and standard deviation used to summarize data subsets.
Chi-square (X2) tests were used to compare proportions
and to test for associations between categorical socio-
demographic variables. T-test or analysis of variance was
used to explore the mean differences of normally distrib-
uted data when appropriate. Respondents’ views about
the interview process were analysed descriptively.
Role of the funding source
The funding source provided financial support for the
first author and had no role in study design, analysis and
interpretation of data and in the writing of this manu-
script or in the decision to submit it. The funding source
provided the permission to collect data and provided




Of 2500 telephone numbers that were dialled, 1226 were
categorized as unsuccessful calls because the number
was not valid (n = 356); there was an “out of service” ring
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tone (n = 276); no one replied (n = 199); there was an en-
gaged ring tone (n = 297); and the number connected to
a fax machine (n = 98). Of the 1274 telephone calls that
were answered 43 respondents did not wish to partici-
pate in the screening interview and 19 respondents were
not eligible for the study because they declared that they
were not Libyan (n = 8) or declared that they were youn-
ger than 18 years of age (n = 11). Thus, 1212 individuals
consented to participate in the survey (response rate = 95 ·
1 %). Mean ± SD age was 37 · 8 ± 13 · 9 years (women =37 ·
7 ± 12 · 5 years, men = 37 · 8 ± 13 · 9 years, range 18 to
72 years) with more women participating than men (women
n = 662, 54 · 6 %, n = 550, 45 · 4 %, z-test = 3 · 2, P =0 · 001).
The demographic characteristics of the 1212 individuals
who were screened are summarized in Table 1.
Prevalence of chronic pain
Of the 1212 individuals who were screened, 238 re-
ported that they experienced pain that had persisted for
at least 3 months (Fig. 1). The prevalence of chronic
pain across the 3 cities was estimated to be 19 · 6 %
(95 % CI 14 · 6 % to 24 · 6 %). The prevalence of chronic
pain in Tripoli was 25 · 1 % (95 % CI 21 · 6 % to 28 · 4 %;
158 of 630 respondents), in Benghazi was 13 · 0 % (95 %
CI 10 % to 16 %, 63 of 483 respondents) and in Sabha was
17 · 2 % (95 % CI = 9 · 6 % to 24 · 4 %, 17 of 99 respon-
dents). There were statistically significant differences in
prevalence between the cities (X2 = 33 · 7, P <0 · 001).
The mean ± SD age of respondents reporting chronic
pain was 45 · 5 ± 1 years and significantly higher than
those that did not report chronic pain (35 · 9 ± 11 · 9, t-
test = −9 · 8, P <0 · 001). The mean ± SD age of men
reporting chronic pain was significantly higher than
women (men = 47 · 7 ± 17 · 4 years, women = 44 · 4 ± 13 ·
8 years, t-test = 3 · 6, P < 0 · 001).
Prevalence increased across the lifespan from 10 · 9 %
(95 % CI 8 · 0-13 · 8) in respondents less than 30 years of
age to 80 · 0 % (95 % CI 59 · 8-100 · 0) in respondents
greater than 70 years of age, although prevalence for the
age category 61–70 years was 22 · 9 % (95 % CI 12 · 4-
33 · 4) and lower than the 51–60 year age category (42 ·
3 %, 95 % CI 34 · 4-50 · 2) and the 41–50 years age
category (31 · 7 %, 95 % CI 25 · 0-38 · 4). Respondents
aged 71 years or older were more likely to report chronic
Table 1 Prevalence of chronic pain, crude odd ratios and odd ratios adjusted for gender and age according to different demographic factors
N (%) *Reference
group
No Pain Pain Prevalence of chronic







Male 550 (45 · 4)* 472 78 14 (11 · 1–16 · 9)
Female 662 (54 · 6) 502 160 24 (20 · 7–27 · 2) 1 · 9 (1 · 4–2 · 6) <0 · 001 1 · 9 (1 · 4–2 · 7) 0 · 000
Age(years)
≤ 30 431 (35 · 6)* 384 47 10 · 9 (8 · 0–13 · 8)
31–40 373 (30 · 8) 329 44 11 · 8 (8 · 5–15 · 1) 1 · 1 (0 · 7–1 · 7) 0 · 691 0 · 9 (0 · 6–1 · 5) 0 · 706
41–50 183 (15 · 1) 125 58 31 · 7 (25 · 0–38 · 4) 3 · 8 (2 · 4–5 · 8) <0 · 001 3 · 3 (2 · 1–4 · 5) 0 · 000
51–60 149 (12 · 3) 86 63 42 · 3 (34 · 4–50 · 2) 6 · 0 (3 · 8–9 · 3) <0 · 001 5 · 1 (3 · 1–8 · 4) 0 · 000
61–70 61 (5 · 0) 47 14 22 · 9 (12 · 4–33 · 4) 2 · 4 (1 · 2–4 · 7) 0 · 009 2 · 4 (1 · 1–5 · 0) 0 · 021
≥ 71 15 (1 · 2) 3 12 80 · 0 (59 · 8–100 · 0) 32 · 6 (8 · 9–120 · 0) <0 · 001 69 · 0 (14 · 0–339 · 9) 0 · 000
Marital status
Single 450 (37 · 1)* 397 53 11 · 8 (8 · 8–14 · 8)
Married 669 (55 · 2) 523 176 26 · 3 (23 · 0–29 · 6) 2 · 5 (1 · 8–3 · 5) <0 · 001 1 · 3 (0 · 9–2 · 1) 0 · 173
Divorced 36 (3 · 0) 31 5 13 · 9 (2 · 6–25 · 2) 1 · 2 (0 · 4–3 · 2) 0 · 707 0 · 5 (0 · 2–1 · 5) 0 · 214
Widowed 57 (4 · 7) 53 4 7 · 2 (0 · 5–13 · 9) 0 · 6 (0 · 19–1 · 6) 0 · 290 0 · 1 (0 · 0–0 · 4) 0 · 002
Employment status
Employed full-time 296 (24 · 4)* 250 46 15 · 5 (11 · 4–19 · 6)
Employed part-time 322 (26 · 6) 275 47 14 · 6 (10 · 7–18 · 5) 0 · 9 (0 · 6–1 · 4) 0 · 743 1 · 2 (0 · 8–2 · 0) 0 · 407
Retired 78 (6 · 4) 53 25 32 · 1 (21 · 7–42 · 5) 2 · 6 (1 · 4–4 · 5) 0 · 001 1 · 2 (0 · 6–2 · 3) 0 · 603
Not employed 317 (26 · 2) 216 101 31 · 9 (26 · 8–37 · 1) 2 · 5 (1 · 7–3 · 8) <0 · 001 2 · 3 (1 · 4–3 · 5) 0 · 000
Student 144 (11 · 9) 127 17 11 · 8 (6 · 5–17 · 1) 0 · 7 (0 · 4–1 · 3) 0 · 029 1 · 1 (0 · 5–2 · 2) 0 · 817
Temporary out of work 55 (4 · 6) 53 2 3 · 6 (1 · 3–8 · 5) 0 · 2 (0 · 0–0 · 9) 0 · 032 0 · 2 (0 · 0–1 · 1) 0 · 063
Total 1212 974 238 19 · 6 (14 · 6–24 · 6)
*Reference group
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pain than other age categories and had a higher odds ratio
for reporting chronic pain than respondents less than
30 years (OR = 32 · 6; 95 % CI 8 · 9-120 · 0, P <0 · 001,
Table 1). Women were more likely to report chronic pain
than men (women = 24 · 0 %, 95 % CI 20 · 7- 27 · 2, men =
14 · 0 %, 95 % CI 11 · 1-16 · 9) irrespective of age (X2 = 1 · 1,
P < 0 · 298, OR = 1 · 9; 95 % CI 1 · 4-2 · 6) and across all age
categories except the age category of 61–70 years (Fig. 2).
The prevalence of chronic pain was higher in respon-
dents that were married (X2 = 42 · 9, P < 0 · 001, OR = 2 · 5;
95 % CI 1 · 8-3 · 5). Widowed respondents were less likely
to report chronic pain than other groups (Table 1). Preva-
lence differed according to employment status (X2 = 61 · 4,
P < 0 · 001). The highest proportion of chronic pain was
reported by retired and unemployed respondents reporting
chronic pain (and the lowest by respondents who were
employed, students, or ‘temporarily out of work’ (Table 1).
The odds ratio for chronic pain was no different in retired
and unemployed respondents than students and ‘temporar-
ily out of work’ (Table 1).
Prevalence of neuropathic pain
The prevalence of neuropathic pain in respondents
reporting chronic pain was 19 · 7 % (95 % CI 14 · 6-24 · 7)
with 47 of 238 chronic pain respondents classified as S-
LANSS positive with a score of ≥12. Thus, the preva-
lence of neuropathic pain in the whole sample was 3 ·
9 %, (95 % CI 2 · 8 to 5 · 0 %).
Fig. 1 Flow chart of results of recruitment
Fig. 2 Age-sex specific prevalence (% out of respondents in each age group) of chronic pain in Libya
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Multivariate analysis
Crude odds ratios found that sex and age were the most
significant factors associated with chronic pain. Being
married, retired or unemployed also increased the odds
ratios of having chronic pain, although being married or
retired was no longer a risk factor when other factors
were incorporated into the equation of logistic regres-
sion and all factors were mutually adjusted (P = 0 · 173,
P = 0 · 603). Adjusted odds ratios showed that unemploy-
ment increased the odds of having chronic pain (OR =
2 · 3; 95 % CI 1 · 4-3 · 5) and being widowed decreased
the odds of having chronic pain (OR = 0 · 1; 95 % CI 0 ·
0-0 · 4). There was a strong correlation between marital
status and age groups (r = −0 · 4, P < 0 · 01) and therefore
marital status was removed from the logistic regression
model and new adjusted odds ratios were produced
(Table 2). Unemployment remained a risk factor of hav-
ing chronic pain but there were no other significant
changes to the odds ratios suggesting that removal of
marital status had little effect on the model.
Duration and frequency of chronic pain
Mean ± SD duration of pain rated on 1–10 numerical rat-
ing scale (NRS) was 6 · 5 ± 5 · 7 years (n = 238). The major-
ity of respondents with chronic pain reported that they
experienced pain that persisted for 2 to 10 years (n = 156
(65 · 5 %)), with 13(5 · 5 %) respondents reporting that they
had experienced pain that persisted for more than 20 years
(Fig. 3). There were no differences in mean ± SD duration
of pain rated at an intensity of 5 or more between women
and men (women = 6 · 6 ± 5 · 9 years, men = 6 · 3 ± 5 ·
3 years, t = −0 · 4; P = 0 · 693, t-test). Of the 238 respon-
dents categorised as having chronic pain, 27 (11 · 3 %)
reported experiencing pain ‘At all times’ and 89 (37 · 4 %)
reported experiencing pain ‘Daily’. Seventy-five (31 · 5 %)
of respondents categorised as having chronic pain re-
ported that they experienced pain ‘Today’ (i.e. on the day
of interview), and 90 (37 · 8 %) reported that they experi-
enced pain ‘Not today, but within the past week’.
Pain intensity, tolerance to pain, and time course of pain
The intensity of the most recent episode of pain in the
238 respondents reporting chronic pain was 7 · 2 ± 1 · 3
on a 10-point numerical rating scale (1 = ‘no pain at all’
and 10 = ‘the worst pain imaginable’), and gleaned from
the question: “Thinking about the last time you experi-
enced pain, please give me a number from 1 to 10 to in-
dicate the intensity of your pain.” One hundred and
forty-six of the 238 (61 · 3 %) respondents reporting
chronic pain rated the intensity of their most recent epi-
sode of pain between 5 and 7 (i.e. moderate) and 92 (38 ·
7 %) rated the intensity of their most recent episode of
pain between 8 and 10 (i.e. severe, Fig. 4). The intensity of
the most recent episode of pain was rated higher for
women compared with men (t = −3 · 505, P < 0 · 01, t-test),
with no differences according to age categories (F = 1 · 0,
P = 0 · 386, oneway ANOVA).
Sixty-seven (28 · 5 %) respondents with chronic pain
reported that “My pain was so severe that I could not
tolerate any more, not even a little” (Fig. 5). One hun-
dred and seventy one (71 · 8 %) respondents with
chronic pain reported their pain was ‘intermittent’ ra-
ther than ‘constant’ to the question, “Would you
describe the pain you generally experience as constant,
on-going pain that is always there or intermittent pain
that comes and goes?”
Body location of pain
Two hundred and sixteen (91 · 5 %) respondents with
chronic pain (n = 236) reported that they experienced
pain in one body site and 16 (6 · 8 %) respondents re-
ported had pain at two sites. The most common sites
of pain gleaned from the screening question: “Where
is your pain located?” (interviewer read from a list of
possible answers, multiple answers accepted) was the
‘back’ (n = 58 (24 · 6 %), unspecified (n = 30), ‘lower
back’ (n = 24) and ‘upper back’ (n = 4)) and the ‘knee’
(n = 31 (13 · 1 %), Fig. 6). There was no difference in
the number of sites of pain across age categories (X2 =
319 · 5; P <0 · 001).
Table 2 Logistic regression model of socio-demographic factors






OR (95 % CI)
P
Gender
Male 550 (45 · 4)*
Female 662 (54 · 6) 1 · 9 (1 · 3–2 · 6) < 0 · 001
Age (years)
<30 431 (35 · 6)*
31–40 373 (30 · 8) 0 · 9 (0 · 6–1 · 5) 0 · 784
41–50 183 (15 · 1) 3 · 4 (2 · 1–5 · 3) < 0 · 001
51–60 149 (12 · 3) 5 · 5 (3 · 4–8 · 5) < 0 · 001
61–70 61 (5 · 0) 2 · 4 (1 · 2–5 · 0) 0 · 017
>71 15 (1 · 2) 34 · 0 (8 · 4–138 · 4) < 0 · 001
Employment status
Employed full-time 296 (24 · 4)*
Employed part-time 322 (26 · 6) 1 · 2 (0 · 7–1 · 9) 0 · 491
Retired 78 (6 · 4) 1 · 1 (0 · 6–2 · 3) 0 · 578
Not employed 317 (26 · 2) 2 · 3 (1 · 4–3 · 5) 0 · 002
Student 144 (11 · 9) 2 · 0 (1 · 3–3 · 1) 0 · 788
Temporary out of work 55 (4 · 6) 0 · 2 (0 · 0–1 · 0) 0 · 053
Total 1212
*Reference group
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Causes of pain
Nine (3 · 8 %) respondents refused to answer the question:
“Please tell me the illness or medical condition that is the
cause of your pain”. Two hundred and three (88 · 6 %) re-
spondents with chronic pain (n = 229) reported one cause
for their pain, 22 reported two causes (9 · 6 %). The most
commonly reported causes were ‘Disc problems’ (n = 45
(19 · 6 %)) and ‘Headaches/migraine’ (n = 35 (15 · 3 %),
Fig. 7). The proportion of respondents reporting ‘Head-
aches/migraines’ was higher in women than men (z = 1 · 9;
P = 0 · 027). In the 203 respondents reporting one cause of
pain ‘Disc problems’ (n = 42 (18 · 3 %)) and ‘Headaches/
migraine’ (n = 34 (14 · 8 %)) were most common.
Pain descriptors
Respondents provided answers to the question: “What
words would you use to describe the pain you generally
experience?” (interviewer read from a list of possible
answers, multiple answers accepted). There were 63
different answers from 238 respondents with 98 respon-
dents providing more than one descriptor for their pain.
The most commonly used words were ‘Aching’ (n = 54),
‘Intense’ (n = 44), ‘Painful’ (n = 35), ‘Annoying’ (n = 16),
and ‘Excruciating’ (n = 24). One hundred-forty respon-
dents (58 · 8 %) used only one word to describe their
pain with ‘Aching’ (n = 27) being the most commonly
used word. Four respondents used ‘Other’ words not
listed in the questionnaire which were ‘Unable to move’
(n = 2) and ‘Hotness’ (n = 2).
Impact of pain on daily activities
Respondents were asked to rate their ability to under-
take daily activities as ‘just as able’, ‘less able’, or ‘no lon-
ger able’ from a list read out by the interviewer. There
were 106 (45 %) of respondents who reported that they
were ‘Just as able’ to participate in all activities read from
the list. Of the 133 (55 %) respondents that reported
pain had reduced their ability to undertake daily activ-
ities the greatest impact was on walking, lifting exercis-
ing and sleeping. Forty three (18 · 1 %) respondents
reported that they were ‘No longer able’ to undertake
‘Lifting’ and 44 (18 · 5 %) were ‘No longer able’ to under-
take ‘Exercising’.
Impact of pain on employment and emotional status
Only 46 (19 · 3 %) respondents reporting chronic pain (n =
238) were in full time employment and 64 (27 · 0 %) were
in part-time employment or were students. Thirty five re-
spondents reported that pain had impacted on their
employment status and 29 reported that they had to change
Fig. 3 Variations in duration of chronic pain of respondents. Data collected from answers to question 6 “For how long have your suffered from
pain due to your illness or medical condition?”
Fig. 4 The intensity of the most recent episode of pain for respondents
with chronic pain (n= 238) in answer to the screening question number
9” Thinking about the last time you experienced pain, please give me a
number from 1 to 10 to indicate the intensity of your pain. Please use a
10-point scale where 1 means” no pain at all” and 10 mean” the worst
pain imaginable”. All participants with chronic pain have scored their
pain 5 or more
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their job responsibilities and 6 reported losing their job or
having to change their job. Respondents who were students
or in full-time or part-time employment reported that they
had lost 10 · 2 ± 5 · 2 days from work (mean ± SD) over the
previous 6 months due to pain. Thirteen of 221(5 · 8 %) re-
spondents reported that they had been diagnosed with
depression because of their pain.
Pain practitioners
Ninety-seven (40 · 8 %) respondents with chronic pain
reported that they had not visited their doctor about
their pain in the previous six months. Of the 141 re-
spondents who had visited their doctor in the previous
6 months, 87 (61 · 7 %) reported visiting their doctor
more than once, with a mean ± SD 2 · 6 ± 1 · 2 visits over
the 6 month period. Nineteen respondents with chronic
pain reported that they had consulted only one doctor
and 199 had consulted more than one doctors. The main
reason for visiting more than one doctor was referral by
another doctor or a recommendation by a friend or a
family member (Fig. 8).
One hundred and thirty eight (57 · 9 %) respondents
had been under the care of their current doctor for man-
agement of their pain for 3 months to 10 years. One
hundred and three (43 · 3 %) respondents were ‘some-
what satisfied’ with the doctor who currently treating
Fig. 5 The “tolerance level” when the pain was at its worst for respondents with chronic pain (n = 235) in answer to the in-depth interview question,”
Thinking about the intensity of your pain when it was at its worst, which of the following statements best describes your tolerance level of this pain”
Fig. 6 Body location of pain in answer the screening question “Where is your pain located”, and respondents providing answers to the
interviewer reading from a list of possible answers, with multiple entries accepted. There were 267 answers (responses) from 236 respondents
with 20 respondents providing multiple sites of pain. Percentage responses were calculated by using 236 as the denominator and therefore totals
exceed 100 %
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Fig. 7 The opinions of respondents on the cause of their pain in answer to the screening question,”Please tell me the illness or medical condition that
is the cause of your pain”. Respondents provided answers to the interviewer reading from a list of possible answers, with multiple entries accepted.
There were 265 answers (responses) from 229 respondents with 26 respondents providing more than one cause for their pain. Percentage responses
were calculated by using 229 as the denominator and therefore totals exceed 100 %
Fig. 8 Reasons why respondents with chronic pain see more than one doctor in answer to the question,”Please tell me your reasons for seeing
more than one doctor for pain treatment?” with multiple entries accepted. Interviewers did not read from a list but categorised responses against
a list on the questionnaire and probed once for ‘what other reasons’. Percentage responses were calculated by using the 208 respondents who
had seen more than one doctor as the denominator and therefore totals exceed 100 %
Elzahaf et al. BMC Public Health  (2016) 16:776 Page 9 of 14
their pain, 71 (29 · 8 %) were ‘very satisfied’ and 21 (8 ·
8 %) were ‘extremely satisfied’. Twenty-seven (11 · 4 %)
respondents were ‘not satisfied’ or ‘not at all satisfied’
with the main reasons being ‘Has not helped me/has not
relieved my pain’ or because they ‘Do not see the same
doctor each time’. One hundred and seventy seven (74 ·
4 %) respondents reported being uncomfortable discuss-
ing their pain with their doctor and preferred to discuss
their pain with family members and/or friends.
Assessment of pain by doctors
One hundred seventy seven (74 · 4 %) respondents re-
ported that their doctor determines how much pain they
were in ‘during every visit’. Twenty (8 · 4 %) respondents
reported that their doctor ‘Never’ assessed their pain
during a consultation. In answer to the question: “How
does the doctor who generally treats your pain deter-
mine how much pain you are in?” 157 (66 · 0 %) respon-
dents reported that ‘I tell him/her’. Only 1 respondent
reported that their doctor used a pain scale to determine
how much pain they were in.
Treatment
Only, 71 (29 · 8 %) of respondents reported that their
pain was being adequately controlled. Thirty seven (15 ·
5 %) respondents reported that they had achieved pain
control between 6 months to one year from the time
when they first experienced pain with 8 (3 · 4 %) respon-
dents reporting that they had been in pain from 5 to
7 years before they received effective treatment. One
hundred and forty six (61 · 3 %) respondents reported
that they were not ‘currently being treated’ for their
pain with the most common reasons being ‘Do not
want surgery’, ‘Can manage pain on own’ and ‘Treat-
ment has not helped’.
One hundred and eighty three (76 · 2 %) respondents
reported that they had taken prescription medicine for
their pain. Forty eight respondents reported that they
never taken prescription medication, of which 14 re-
ported that they could ‘Manage/live with the pain’, 14
reported that pain medication was ‘Never prescribed’,
and 9 reported that ‘Pain was not bad enough’. One
hundred and five (44 %) respondents reported that
they had stopped taking prescription medicine with
reasons including ‘Manage/live with the pain’ and ‘Ran
out of medication’.
One hundred and three of 156 respondents to the
question: “How many different kind of prescription pain
medicines have you ever taken for your pain?” reported
that they had taken one to two types of prescription
medications and 53 respondents reported that they had
taken three to eleven types of prescription medications.
Forty two respondents reported that their doctor had
‘switched prescription pain medicines’ or ‘prescribed
more than one medicine for the same pain’. The most
common reason reported for switching pain medication
was ‘Pain became worse’. Only 69 respondents were able
to name the drug that they were currently being pre-
scribed and only three prescription medicines were
named (‘Voltarol’, ‘Ibuprofen’ and ‘Paracetamol’). No re-
spondents reported that their current prescription pain
medication was ‘Completely effective’ while 24 reported
that they were ‘very effective’.
Ninety nine (41 · 6 %) respondents reported that they
had taken non-prescription oral pain medicine in the
last six months and 87 of these respondents reported
that they had taken one or two non-prescription oral
pain medications. The most commonly reported non-
prescription oral pain medicines were non-steroidal
anti-inflammatory medication (n = 55, ‘Voltarol’, ‘Ibupro-
fen’, ‘Aspirin’) and paracetamol (n = 27). Respondents re-
ported that their non-prescription medicines were ‘Not
very effective’ or ‘Not at all effective’ (n = 19), ‘Somewhat
effective’ (n = 67), and ‘Very effective’ or ‘Completely
effective’ (n = 13).
Two hundred and seven (87 %) respondents reported
that they had used non-drug methods to treat their pain
and the majority of these reported that they used only
one non-drug treatment (n = 116). Physical therapy,
massage and herbal supplements were reported to be
the most commonly used non-drug methods to treat
pain. Forty six respondents reported that the methods
were ‘Extremely successful’, 125 respondents ‘Somewhat
successful’, 19 respondents ‘Very successful’ and 17 re-
spondents ‘Not very successful’.
One hundred and one (42 · 4 %) respondents reported
that they had been ‘treated for pain’ or ‘seen a doctor in
another country’, with ‘Better access [to pain treatment]’
(n = 49) and ‘Better reimbursement in the other country’
(n = 36) being the most common reasons. Egypt and
Tunisia were the most common countries used in
addition to Jordan and England.
Attitudes and beliefs about pain and its treatment
The interviewer read 33 statements describing how
people experiencing pain think and feel about their pain
and the respondent was asked to reflect on their own
pain and to ‘completely’ or ‘somewhat’ agree or disagree
with each statement using a 5-point Likert scale. This
task was toward the end of the interview and only 71
(29 · 8 %) respondents agreed to rate the statements.
Pain clearly impacted on daily activities and a sense of
wellbeing. Six respondents replied (8 · 5 %) ‘agreed com-
pletely’ and 27 (38 %) ‘agreed somewhat’ that ‘I cannot
function normally’. Twenty nine respondents (40 · 8 %)
‘agreed completely’ or ‘agreed somewhat’ with the state-
ment ‘Some days the pain is so bad, I want to die’. Six of
Elzahaf et al. BMC Public Health  (2016) 16:776 Page 10 of 14
the 71 respondents (8 · 2 %) respondents ‘agreed com-
pletely’ and 17 (23 · 3 %) ‘agreed somewhat’ that ‘I worry
about what people would think if they knew I take pain
medicine’ and 18 (25 · 4 %) respondents agreed com-
pletely that ‘I would spend all my money on pain treat-
ment if I knew it would work’. Fifteen of the 71 (21 ·
1 %) respondents completely agreed that ‘My doctor
would rather treat my illness than my pain’ and 11
(15 %) reported that ‘I think my doctor does not know
how to control my pain’.
Discussion
This is the first study to estimate the prevalence of
chronic pain in Libya. It was found that the prevalence
in adult general population was 19 · 6 %. This is lower
than the overall weighted mean prevalence worldwide
that was found to be 30 · 3 % ± 11 · 7 % by Elzahaf and
colleagues [7] and lower than the previous worldwide es-
timates by Smith & Torrance [16], which was 22 · 9 %
(95 % CI 22 · 7 %- 23 · 2 %), and Harstall & Ospina [17],
which was 35 · 5 %. Perhaps most importantly, the
Libyan estimate was lower than the weighted mean
prevalence in the Middle East and North Africa, which
was found to be 28 · 0 % ± 9 · 2 [7, 12] and lower than es-
timates of individual counties in the region (e.g. Lebanon
(26 · 2 % [8]) and Turkey (28 · 9 % [9]). It is, however,
comparable to a recent telephone survey of 16 regions
of Morocco that estimated prevalence of reported
chronic daily pain for more than 3 months in the general
population as 21 % (95 % CI: 19 · 9-22 · 2), and higher in
women and individuals older than 60 [18].
The Libyan estimate was also comparable to the over-
all prevalence of chronic pain in Europe (19 % [10]) and
Canada (18 · 9 % [19]) which gathered data using the
same Structured Telephone Interviews Questionnaire on
Chronic Pain as used in this Libyan study. Libya is
classified as a developing country with an HDI of 0 · 784
(2013) and the Libyan estimate of prevalence was lower
than many estimates from countries with similar HDIs <0 ·
9 including Colombia (27 · 3 %, HDI = 0 · 807, [8]),
Brazil (30 · 8 %, HDI = 0 · 790, [9]), Mexico (24 · 1 %,
HDI = 0 · 854, [8]), Chile (33 %, HDI = 0 · 719, [9]),
South Africa (48 · 3 %, HDI = 0 · 683, [8]), Nigeria (30 ·
4 %, although one survey reported 5 · 5 %, HDI = 0 · 511,
[8, 9]), and India (19 %, HDI = 0 · 566, [9]).
This survey estimated that the prevalence of neuro-
pathic pain in the general adult population of Libya
using the S-LANSS questionnaire was 3 · 9 % (95 % CI =
1 · 4 % to 6 · 4 %). This estimate is similar to surveys in
Austria (3 · 3 %) [20] and Spain (3 · 3 %) [21] but lower
than the UK (8 · 2 %, [22]), Canada (17 · 9 %, [23]) and
France (6 · 9 %, [24]). In Western Europe, direct medical
costs associated with neuropathic pain was found to be
approximately twice as high as non-neuropathic pain
[25]. No such direct medical costing was attempted in
this study in Libya but anecdotal evidence suggests that
a high number of patients with untreated pain seek pain
management services and advice from outside the coun-
try, which is likely to be expensive. Further research is
needed on the aetiology of neuropathic pain in Libya.
The main causes of chronic pain in Libya were back
pain, osteoarthritis, rheumatoid arthritis and headaches,
and similar to that reported by Breivik and colleagues
[10] in the pan-European survey. Breivik and colleagues
[10] found that at least 15 % of chronic pain conditions
resulted from trauma or surgery although only 5 · 9 % of
chronic pain conditions were in this category from our
Libyan survey. We suspect that this was because of
fewer surgical procedures performed in Libya compared
with countries in Europe because of many Libyan pa-
tients undergoing surgeries abroad [26].
It was found that in Libya women were more likely to
have chronic pain than men, a finding consistent with pre-
vious surveys regardless of survey method used [10, 15,
22, 24, 27, 28]. The odds ratio was 1 · 9 and higher than re-
cent surveys in Ireland (1 · 0, [14]), Hong Kong (1 · 5, [15]),
and lower than a recent survey in Portugal (2 · 3 [29]).
Research evidence supports sex-based differences in pain
experience [30–32] including a higher prevalence and se-
verity of chronic pain in women than men [33]. Tashani
and colleagues [34] have found that Libyan women have
greater sensitivity to experimentally induced pain than
Libyan men and that there is a strong correlation be-
tween gender role and pain sensitivity response [35].
The present findings provide more evidence that this
trend is universal.
Our survey found that in Libya the prevalence of
chronic pain increased with age and this is consistent
with previous studies [28, 29, 36, 37]. In Libya, the
prevalence of chronic pain was highest in the oldest age
group (>70 years), although the sample size in this age
category was small. We suspect that the higher preva-
lence of chronic pain in old age was related to an in-
creased possibility of having a chronic progressive
disease [38].
The demographic factors which were associated with
an increased likelihood of having chronic pain in Libya
were being a woman, of advanced age and unemployed.
In Libya women are more likely to be unemployed than
men so there is co-linearity between unemployment and
being a woman, and therefore being unemployed in
Libya is probably not a strong risk factor for having
chronic pain. It is also possible that, at least for a pro-
portion of the population, being out of employment
could be the result of having chronic pain. In Libya,
sexual relationships outside of wedlock are prohibited
and socially unacceptable and therefore most women are
married. We found that the significance of being
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married as a risk factor for chronic pain disappeared
when adjusted for sex and age.
A large proportion of Libyan adults with chronic pain
reported taking prescription medicine to treat their pain
with NSAIDs being the most common class of analgesic
medication used. This finding is consistent with other
surveys in other regions of the world [10, 39–44]. In
Libya, the use of opioid analgesics is only available via
prescription [45]. Soyannwo [46] reported that in re-
source limited countries there is a fear of opioid abuse,
dependence, and addiction. For example, a study con-
ducted in Nepal found that opioid analgesics were not
used by chronic pain patients [39]. Legal restrictions,
policy, knowledge and attitudes continue to contribute
to the unavailability of opioid analgesics in the Middle
East and North Africa. There is a need for education
and training programmes in Libya about the use of
opioids in treating chronic pain patients.
One unexpected finding from the present study was
the similarity of non-pharmacological approaches to re-
duce pain with that found in the pan-European survey,
with few ‘traditional remedies’ reported to be used by
Libyan respondents. The Libyan sample was taken from
large cities where individuals had access to modern
health care services, similar to those found in resource
rich countries. Non pharmacological approaches for the
management of pain tend to be delivered by physiother-
apists within rehabilitation services in a manner similar
to that seen in European countries. Some of the physio-
therapists are qualified to BSc level and they work within
multi-disciplinary teams in a variety of medical depart-
ments in public hospitals. Nevertheless, equipment,
facilities and time spent with patients is often inadequate
due to limited resources. In recent years the need for
physiotherapy and rehabilitation services has increased
as a result of the conflict and the number of private
clinics is on the rise. A minority of respondents reported
that they had tried to treat their pain with olive oil (or-
ally or topically), cupping (Hjama), burning skin (Kai)
and local herbal concoctions (Kmra).
Limitations
Estimation of chronic pain in the general population
relies on recall of pain status during a defined period of
time and is susceptible to recall bias and therefore infer-
ences are made with caution. Some questions relied on
respondents to self-report their condition and the accur-
acy of these reports is likely to be poor, especially for
specific diagnoses such as “disc problems” which are
challenging to medical specialists even with in-depth
clinical assessments and the most sophisticated of
technology. Moreover, data was collected from a cross-
sectional survey and in some instances it was unclear
whether the respondents were describing pain before,
during or after treatment. Elderly respondents who had
difficulty communicating were helped by other members
of the household, which may have influenced their re-
sponses. The questionnaire used to collect data was de-
signed for use in European countries and was translated
and culturally adapted for use in Libya. However, some
questions or words, which were designed for European
patients, could have being misunderstood by Libyans re-
spondents in the same way.
The most obvious direction for future research is to
conduct a post-conflict follow-up study as this would
provide valuable information about trends in the preva-
lence of chronic pain in regions affected by conflict. This
would enable policy makers to undertake up-to-date
analyses of pain management needs. A future study
could also adjust for factors such as smoking and body
mass index.
Conclusion
The prevalence of chronic pain ≥ 3 months in the general
adult population of 3 major cities in Libya was estimated
to be 19 · 6 % (95 % CI = 14 · 6 % to 24 · 6 %) with the
prevalence of neuropathic pain being 3 · 9 %, (95 % CI: 2 ·
8 to 5 · 0 %). This suggests that chronic pain is a public
health problem in Libya with a prevalence comparable to
Europe. Risk factors were being a woman, advanced age
and unemployment. There is a need for improved pain
management policies in Libya to ensure that patients with
chronic pain receive effective treatment.
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